How Much Did Ajes Pharmaceuticals Raise?
Funding & Key Investors

Ajes Pharmaceuticals has secured $136K in total capital, with its most recent financing round bringing in $136K in a major strategic investment. This significant backing underscores the company's established position in the market and its trajectory for continued development.

What is Ajes Pharmaceuticals?

Ajes Pharmaceuticals
ManufacturingPharmaceuticalsHealth & Nutrition Products

Ajes Pharmaceuticals LLC, based in Copiague, New York, operates as a licensed and registered contract manufacturer within the nutraceutical and pharmaceutical sectors. The company specializes in producing a diverse array of products, including gummies, tablets, capsules, powders, and liquids. Ajes Pharmaceuticals distinguishes itself through its custom formulation and packaging services, meticulously designed to cater to the specific requirements of its clientele. Leveraging a team of seasoned chemists and a cutting-edge manufacturing facility, the company is dedicated to fostering quality and innovation in the production of dietary supplements. Its primary focus is on serving businesses that seek dependable and effective manufacturing solutions for their dietary supplement lines.

How much funding has Ajes Pharmaceuticals raised?

Ajes Pharmaceuticals has raised a total of $136K across 1 funding round:

2021

Debt

$136K

Debt (2021): $136K with participation from PPP

What's next for Ajes Pharmaceuticals?

The substantial large-scale late-stage funding indicates Ajes Pharmaceuticals is poised for significant expansion and operational enhancement. This capital infusion is likely to fuel advancements in manufacturing capabilities, potentially broadening product lines, and strengthening market reach. Strategic investments at this stage often signal a company's readiness to scale operations, invest in research and development, and solidify its competitive advantage in the dynamic nutraceutical and pharmaceutical contract manufacturing landscape. Future growth may involve strategic partnerships, technological upgrades, and an increased capacity to serve a larger client base, reinforcing its role as a key player in the industry.

See full Ajes Pharmaceuticals company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Chemicals & Related ProductsManufacturingBuilding MaterialsPlastic, Packaging & Containers
ManufacturingMedical Devices & Equipment
Food & BeverageManufacturingRetailGrocery RetailHospitalityRestaurant Reservations
ManufacturingTextiles & Apparel

Frequently Asked Questions Regarding Ajes Pharmaceuticals Financial Insights

What are the most recent funding rounds that Ajes Pharmaceuticals has completed, and what were the funding rounds?
Ajes Pharmaceuticals has recently completed 1 funding rounds: Debt on Jan 28, 2021.
What is the total amount of funding Ajes Pharmaceuticals has raised to date?
Ajes Pharmaceuticals has raised a total of $136K in funding to date.
How many funding rounds has Ajes Pharmaceuticals completed?
Ajes Pharmaceuticals has completed 1 funding rounds.
How much funding did Ajes Pharmaceuticals raise in its most recent funding round?
Ajes Pharmaceuticals raised $136K in its most recent funding round.
Who are the lead investors in Ajes Pharmaceuticals's latest funding round?
The lead investor in Ajes Pharmaceuticals's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Ajes Pharmaceuticals's history?
The largest funding round in Ajes Pharmaceuticals's history was $136K.
See more information about Ajes Pharmaceuticals